C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2011
10/19/2011	CN102219751A Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof
10/19/2011	CN102219750A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/19/2011	CN102219745A 2-aryl substituted benzimidazole derivatives, as well as preparation method and application thereof
10/18/2011	US8039638 Inhibitors of HIV replication
10/18/2011	US8039637 Process for preparing benzimidazole compounds
10/18/2011	US8039622 Melanocortin receptor agonists
10/18/2011	US8039619 Process for preparing (2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
10/18/2011	US8039498 Imidazole compounds
10/18/2011	US8039495 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
10/18/2011	US8039486 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
10/18/2011	US8039474 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	US8039076 Dye and recording media utilizing the same
10/18/2011	CA2494049C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/18/2011	CA2360275C Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/13/2011	WO2011125317A1 Triazole derivative and pest control agent
10/13/2011	WO2011124638A1 Pimobendan manufacturing process
10/13/2011	WO2011124580A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	WO2011123947A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
10/13/2011	WO2011123946A1 Kinase inhibitors and method of treating cancer with same
10/13/2011	WO2011123937A1 Kinase inhibitors and method of treating cancer with same
10/13/2011	WO2011083495A3 Process for the preparation of dihydroxy protected derivatives and novel intermediate compounds
10/13/2011	WO2011082266A3 Substituted heterocyclic compounds
10/13/2011	WO2011038086A3 Indolizine inhibitors of 5-lipoxygenase
10/13/2011	US20110252507 Transgenic plants used as a bioreactor system
10/13/2011	US20110251401 Polyphenylene host compounds
10/13/2011	US20110251395 Oxygen scavenging molecules, articles containing same, and methods of their use
10/13/2011	US20110251212 Piperazine derivatives
10/13/2011	US20110251208 Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
10/13/2011	US20110251207 Biaryl-spiroaminooxazoline analogues as alpha 2c adrenergic receptor modulators
10/13/2011	US20110251199 Nitrogen-containing bicyclic heteroaryl compounds and methods of use
10/13/2011	US20110251181 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
10/13/2011	US20110251176 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	US20110251174 2,4-diamino-pyrimidines as aurora inhibitors
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251169 Arylethynyl derivatives
10/13/2011	US20110251168 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/13/2011	US20110250145 Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
10/13/2011	US20110250135 Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their Use
10/13/2011	US20110248257 Compound for an organic photoelectric device, organic photoelectric device, and display device including the same
10/13/2011	CA2794801A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/13/2011	CA2792641A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
10/13/2011	CA2791324A1 Kinase inhibitors and method of treating cancer with same
10/12/2011	EP2374804A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011	EP2374794A1 Cyclic amine compounds
10/12/2011	EP2374791A1 Insecticidal 4-phenyl-1H pyrazoles
10/12/2011	EP2373658A2 Stat3 inhibitors and therapeutic methods using the same
10/12/2011	EP2373646A1 Phthalazinone and related analogs as sirtuin modulators
10/12/2011	EP2373645A1 Isoindolinone and related analogs as sirtuin modulators
10/12/2011	EP2373644A1 Pyridazinone derivatives
10/12/2011	EP2373643A2 Novel polymorphs of sunitinib malate
10/12/2011	EP2373642A2 Process for the preparation of sunitinib malate via sunitinib acetate and their polymorphs
10/12/2011	EP2373641A1 Pyridazinone derivatives
10/12/2011	EP2373636A1 Inhibitors of phosphoinositide dependent kinase 1 (pdk1)
10/12/2011	EP2373630A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
10/12/2011	EP2373626A1 Substituted indazole derivatives active as kinase inhibitors
10/12/2011	EP2373313A1 Substituted pyrazole compounds
10/12/2011	EP2373172A1 Inhibitors of hcv ns5a
10/12/2011	EP2373168A1 Inhibitors of hcv ns5a
10/12/2011	EP2373167A1 Inhibitors of hcv ns5a
10/12/2011	EP2229356B1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
10/12/2011	EP1761522B1 Compounds and methods for treating dyslipidemia
10/12/2011	CN1934101B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/12/2011	CN1849318B Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/12/2011	CN1702065B Fluorene-based compound and organic electroluminescent display device using the same
10/12/2011	CN102216292A Tetrasubstituted pyridazines HEDGEHOG pathway antagonists
10/12/2011	CN102216291A Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
10/12/2011	CN102216277A Novel compounds as cannabinoid receptor ligands
10/12/2011	CN102216276A Heteroaryls amide derivatives and their use as glucokinase activators
10/12/2011	CN102216270A Novel bis-amides as antimalarial agents
10/12/2011	CN102216268A Novel estrogen receptor ligands
10/12/2011	CN102212059A Method for cyclically preparing ramosetron hydrochloride by racemization
10/12/2011	CN102212058A Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
10/12/2011	CN101421252B 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
10/12/2011	CN101296909B Pyrazine derivatives and use as pI3K inhibitors
10/12/2011	CN101258134B 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011	US8034835 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs
10/11/2011	US8034832 Gyrase inhibitors and uses thereof
10/11/2011	US8034820 Pharmaceutical composition
10/11/2011	US8034815 Imidazol-1-yl-(4-pyridin-2-yl-piperazin-1-yl)-methanethione; Critical Outcome Technologies' Iead compound (COTI); kinase inhibitor; anticarcinogenic agent; especially small cell lung cancer; cervical, ovarian, skin, prostate, breast, colorectal, head, neck, or kidney cancer, sarcoma, leukemia
10/11/2011	US8034622 Selective detection of Hg2+ by calix[4]arenes
10/11/2011	CA2655395C Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
10/11/2011	CA2578066C Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
10/11/2011	CA2555216C Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
10/11/2011	CA2551909C Substituted azole derivatives, compositions, and methods of use
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/11/2011	CA2504907C Indoles useful in the treatment of androgen-receptor related diseases
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/06/2011	WO2011123751A2 Heterocyclic compounds and their uses
10/06/2011	WO2011123674A1 Compounds for treating neurodegenerative diseases
10/06/2011	WO2011122815A2 Novel quinoxaline derivatives
10/06/2011	WO2011122637A1 Succinimide compound, lubricating oil additive, and lubricating oil composition
10/06/2011	WO2011122381A1 Novel organic compound and organic light-emitting device having the same
10/06/2011	WO2011121629A1 Indolic derivatives and use thereof in medical field

1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 626